etoposide has been researched along with Cancer, Second Primary in 226 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 83 (36.73) | 18.2507 |
| 2000's | 98 (43.36) | 29.6817 |
| 2010's | 35 (15.49) | 24.3611 |
| 2020's | 10 (4.42) | 2.80 |
| Authors | Studies |
|---|---|
| Moore, KJ; Snow, S; Wood, LA | 1 |
| Ghandour, K; Halalsheh, H; Ibrahimi, AKH; Ismael, T; Sarhan, N; Shehadeh, A; Sultan, I; Zandaki, D | 1 |
| Hu, H; Huang, D; Li, F; Li, J; Li, R; Liu, Z; Zhang, W | 1 |
| Hao, J; Jing, Y; Wu, W; Xu, Q | 1 |
| Kajita, N; Makimoto, A; Miyahara, S; Saito, Y; Yuza, Y | 1 |
| Au-Yeung, R; Chan, TSY; Ip, AHW; Kwong, YL; Pang, AWK | 1 |
| André, MPE; Bellei, M; Brice, P; Brière, J; Carde, P; Casasnovas, O; Clément-Filliatre, L; Depaus, J; Douxfils, J; Dupuis, J; Federico, M; Fortpied, C; Gianni, AM; Gobbi, PG; Heczko, M; Hutchings, M; Iannitto, E; Mounier, N; Rambaldi, A; Valagussa, P; Viviani, S; Zinzani, PL | 1 |
| Altmann, B; Banos, A; Bay, JO; Bilger, K; Bouabdallah, K; Braulke, F; Cartron, G; Damaj, G; de Leval, L; Delmer, A; Dreger, P; Dreyling, M; Friedrichs, B; Gaulard, P; Gisselbrecht, C; Glass, B; Gyan, E; Haenel, M; Jaccard, A; Keller, U; Kroschinsky, F; Lamy, T; Leclerc, M; Lindemann, W; Metzner, B; Milpied, N; Nickelsen, M; Poeschel, V; Reimer, P; Rosenwald, A; Roussel, M; Sanhes, L; Schmitz, N; Sibon, D; Tournilhac, O; Truemper, L; Viardot, A; Wagner, E; Wilhelm, M; Wulf, G; Ziepert, M | 1 |
| Cui, F; Yan, J; Zhao, S | 1 |
| Borchmann, P; Breywisch, F; Damaschin, C; Eichenauer, DA; Engert, A; Fuchs, M; Goergen, H; Kreissl, S; Mathas, S; Meissner, J; Plütschow, A; Sökler, M; Topp, MS; von Tresckow, B; Vucinic, V; Zimmermann, A | 1 |
| Borchmann, P; Borchmann, S; Bröckelmann, PJ; Buerkle, C; Diehl, V; Engert, A; Fuchs, M; Goergen, H; Kreissl, S; Müller, H; Plütschow, A; Sasse, S | 1 |
| Erdelkamp, R; Hentrich, M; Stief, C; Tritschler, S | 1 |
| Hiraga, J; Kagami, Y; Narita, M; Suzuki, N; Takagi, Y; Tomita, A | 1 |
| Ahmad, A; Banerjee, S; Berney, DM; Graham, R; Hockings, H; Ledermann, J; Liberale, V; Lockley, M; Murali, K; Newton, C; Sarker, SJ; Shamash, J; Stoneham, S | 1 |
| Bartlett, NL | 1 |
| Asamura, H; Eba, J; Katayama, H; Kenmotsu, H; Niho, S; Shibata, T; Tamura, T; Tsuboi, M; Watanabe, S; Yamamoto, N | 1 |
| Behringer, K; Böll, B; Borchmann, P; Diehl, V; Eichenauer, DA; Engert, A; Franklin, J; Fuchs, M; Halbsguth, T; Haverkamp, H; Klimm, B; Rothe, A; Sasse, S; Thielen, I; von Tresckow, B | 1 |
| Su, Y; Zhang, L; Zhang, R; Zhou, X | 1 |
| Maherus, EM; Rashidi, A | 1 |
| Fey, MF; Karamitopoulou-Diamantis, E; Studer, UE; Thalmann, GN; Vidal, AD | 1 |
| Camarata, M; Cooke, R; Dancy, G; Krell, J; Kwan, A; O'Nions, J; Savage, P; Seckl, MJ; Short, D; Swerdlow, A | 1 |
| Cosio, S; Gadducci, A; Lanfredini, N | 1 |
| Apel, A; Avigdor, A; Ben-Bassat, I; Dann, EJ; Davidson, T; Kedmi, M; Levi, I; Nagler, A; Polliack, A | 1 |
| Angrilli, F; Baldini, L; Cascavilla, N; Federico, M; Ferrari, A; Galimberti, S; Gobbi, PG; Ilariucci, F; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Musso, M; Polimeno, G; Scalzulli, PR; Stelitano, C | 1 |
| Bowers, SP; Gibson, S; Reed, N; Spiliopoulou, P; White, J | 1 |
| Baser, E; Cetinkaya, N; Gungor, T; Irkkan, C; Korkmaz, E; Yakut, HI | 1 |
| Jeong, JS; Kim, SR; Lee, JH; Lee, YC | 1 |
| Agerbaek, M; Andersen, KK; Bandak, M; Dalton, SO; Daugaard, G; Hansen, MK; Holm, NV; Johansen, C; Kier, MG; Lauritsen, J; Mortensen, MS | 1 |
| Azuma, E; Hirayama, M; Imai, H; Iwamoto, S; Komada, Y; Matsumine, A; Miura, Y; Nakatani, K; Toyoda, H; Yodoya, N | 1 |
| Chen, JY; Lu, C; Tang, X; Wang, JW | 1 |
| Bai, CH; Kim, YD; Song, SY; Woo, HJ | 1 |
| Bourgeois, JM; Hodson, I; Macdonald, P; Midia, M; Mullah-Ali, A; Portwine, C; Ramsay, JA | 1 |
| Kawase, T; Mikami, S; Oya, M; Takahashi, S; Yoshida, K | 1 |
| Gutweiler, JR; Kim, HB; Kozakewich, HP; Marcus, KJ; Shamberger, RC; Weldon, CB; Yu, DC | 1 |
| Kim, KJ; Kim, YD; Lee, YH | 1 |
| Alexander, C; Bashford, J; Jefferies, PD; Lee, GA; Whitehead, K | 1 |
| Crump, M; Keating, A; Kuruvilla, J; Pintilie, M; Seshadri, T; Tsang, R; Zadeh, S | 1 |
| Ariffin, H; RamaChandran, S | 1 |
| Inagaki, H; Iwashima, Y; Kusumoto, S; Kutsuna, T; Maeno, K; Miyazaki, M; Nakamura, A; Nakao, M; Oguri, T; Ota, C; Ozasa, H; Sato, S; Takakuwa, O; Ueda, R; Uemura, T | 1 |
| Cheson, BD | 1 |
| El-Baz, M; Ghali, AM; Ghoneim, MA; Sarhan, MM; Sarhan, OM | 1 |
| Diehl, V; Engert, A; Franklin, J; Hasenclever, D; Josting, A; Loeffler, M; Scholz, M | 1 |
| Khunamornpong, S; Settakorn, J; Siriaunkgul, S; Sukpan, K; Suprasert, P | 1 |
| Andresen, S; Avalos, B; Bolwell, BJ; Copelan, E; Dean, R; Devine, S; Elder, P; Kalaycio, M; Mahindra, A; Pohlman, B; Rybicki, L; Sobecks, R; Sweetenham, J; Tench, S | 1 |
| Douer, D; Liu, SV; Tahbaz, A; Zneimer, S | 1 |
| Arima, R; Kuratsu, J; Makino, K; Nakamura, H; Ushio, Y | 1 |
| Leahey, A; Meadows, AT; Shields, CL; Turaka, K | 1 |
| Cha, YJ; Kim, HR; Kim, JW; Park, EK; Yu, N | 1 |
| Bain, BJ; Innes, A; May, PC; Pavlů, J | 1 |
| Chang, TC; Chen, CH; Chen, RJ; Chou, CH; Sheu, BC | 1 |
| Ma, X; Ren, C; Sheng, Z; Wang, B; Xia, B; Zhang, W | 1 |
| Adachi, N; Austin, CA; Cowell, IG; Jackson, GH; Lee, KC; Manville, CM; Padget, K; Rance, HA; Sidorczuk-Lesthuruge, M; Smith, K; Sondka, Z | 1 |
| Austin, CA; Cowell, IG | 1 |
| Axcrona, U; Brabrand, S; Cvancarova, M; Fosså, SD; Lehne, G | 1 |
| Agha, M; Boyiadzis, M; Duggal, S; Hou, JZ; Im, A; Lin, Y; McLaughlin, B; Raptis, A; Redner, R; Smith, C | 1 |
| Fujii, H; Iwai, T; Nakagawa, H; Ueda, Y | 1 |
| Hamaguchi, H; Morita, Y; Nagata, K; Yamamoto, K | 1 |
| Badros, A; Barlogie, B; Morris, C; Tricot, G; Zangari, M | 1 |
| Bahng, HS; Jang, GD; Jeong, YH; Ji, HS; Kim, EK; Kim, SH; Kim, SW; Kim, WK; Lee, JS; Park, CJ; Park, IG; Suh, CW; Suh, EJ | 1 |
| Au, WY; Chim, CS; Chung, LP; Kwong, YL; Ma, SK | 1 |
| Berger, SJ; Cooper, BW; Donaher, E; Gerson, SL; Gosky, DM; Green, SB; Hoppel, CL; Ingalls, ST; Lazarus, HM; Li, X; Rosenthal, NS | 1 |
| Behm, FG; Blanco, JG; Boyett, JM; Evans, WE; Kun, LE; Pui, CH; Raimondi, S; Relling, MV; Rivera, GK; Sandlund, JT | 1 |
| Beck, JD; Borkhardt, A; Creutzig, U; Harbott, J; Jacobs, U; Langer, T; Leis, T; Metzler, M; Rascher, W; Reichel, M; Reinhardt, D; Repp, R; Ritter, J; Schrappe, M; Stanulla, M; Viehmann, S | 1 |
| Bayle, C; Bernheim, A; Cayuela, JM; Chompret, A; de Vathaire, F; Hill, C; Lacour, B; Le Deley, MC; Leblanc, T; Raquin, MA; Shamsaldin, A; Sommelet, D; Vassal, G | 1 |
| Kadowaki, S; Kawakami, K; Watanabe, Y | 1 |
| Badenoch, D; Berney, D; Nargund, V; Oliver, RT; Ong, J; Shamash, J | 1 |
| DeVita, VT | 1 |
| Diehl, V; Dörken, B; Dühmke, E; Franklin, J; Hasenclever, D; Herrmann, R; Lathan, B; Loeffler, M; Müller-Hermelink, HK; Paulus, U; Pfreundschuh, M; Tesch, H | 1 |
| Das, M; Gmori, M; Konstantini, S; Nagler, A; Panigrahi, S; Slavin, S; Stagler, D | 1 |
| Einhorn, LH; Foster, RS; Henley, JD; Sheski, FD | 1 |
| Alken, P; Häcker, A; Hatzinger, M; Knoll, T; Köhrmann, KU; Michel, MS; Siegsmund, M | 1 |
| Chin, K; Furuta, N; Hatake, K; Itoh, Y; Mishima, Y; Mizunuma, N; Nagasaki, E; Shinozaki, E; Takahashi, S; Terui, Y; Tokutome, N; Usui, N | 1 |
| Christodoulou, J; Haferlach, T; Schnittger, S; Schoch, C | 1 |
| Kondo, T; Mikami, M; Nakanishi, H; Otsuki, T; Suemori, S; Suetsugu, Y; Sugihara, T; Tsujioka, T; Wada, H; Yamamori, S | 1 |
| Antoch, G; Debatin, JF; Gutzeit, A | 1 |
| Amato, RJ; Ayala, AG; Ro, JY; Swanson, DA | 1 |
| Ayan, I; Görgün, O; Kebudi, R | 1 |
| Akihama, S; Habuchi, T; Iinuma, M; Kato, T; Mitsumori, K; Ohyama, C; Saito, M; Sato, K; Satoh, S; Shimoda, N; Terai, Y | 1 |
| Richter, P; Solecki, R; Szura, M; Zajac, A | 1 |
| Calabrese, L; Cavalli, F; Cocorocchio, E; Ghielmini, M; Martinelli, G; Mazzetta, C; Pastano, R; Peccatori, F; Pruneri, G; Saletti, PC; Zucca, E | 1 |
| Avalos, B; Bechtel, T; Copelan, E; Elder, P; Ezzone, S; Farag, S; Hoshaw-Woodard, S; Lemeshow, S; Lin, T; Marcucci, G; Penza, S; Scholl, MD | 1 |
| deVere White, RW; Ellison, LM; Gandour-Edwards, R; Goldberg, Z; Karpman, E; Saffarian, A | 1 |
| Billups, CA; Davidoff, AM; Krasin, MJ; Kun, LE; Merchant, TE; Neel, MD; Rodriguez-Galindo, C | 1 |
| Felix, CA; Libura, J; Richardson, C; Slater, DJ | 1 |
| Deguchi, N; Kuroda, I; Mitsuhashi, T; Nakagawa, K; Tsukamoto, T; Ueno, M; Yanaihara, H | 1 |
| Sadahira, Y; Suemori, S; Sugihara, T; Tsujioka, T; Wada, H | 1 |
| Eden, OB; Ng, A; Ravetto, PF; Taylor, GM; Wynn, RF | 1 |
| Bajor, DL; Bedi, T; Cooper, BW; Creger, RJ; Fox, RM; Fu, P; Gerson, SL; Koc, ON; Laughlin, MJ; Lazarus, HM; Payne, J; Wadhwa, PD | 1 |
| Boehlke, I; Bokemeyer, C; Hartmann, JT; Kanz, L; Kollmannsberger, C; Kuczyk, M; Metzner, B; Schleicher, J; Schleucher, N; Wierecky, J | 1 |
| Bogart, J; Evans, L; Green, MR; Herndon, JE; McClay, EF; Seagren, SL; Watson, D | 1 |
| Birtle, AJ; Huddart, RA | 1 |
| Hartmann, O; Le Deley, MC; Leblanc, T; Shamsaldin, A; Taïbi, A; Vassal, G | 1 |
| Adès, L; Blair, IA; Cassinat, B; Chomienne, C; Cross, NC; Felix, CA; Fenaux, P; Grimwade, D; Lafage-Pochitaloff, M; Mason, A; Mistry, AR; Osheroff, N; Parry, A; Peniket, AJ; Reiter, A; Segal, MR; Solomon, E; Walz, C; Whitmarsh, RJ; Wiemels, JL | 1 |
| Bouffet, E; Foreman, N; Korones, DN; Smith, A | 1 |
| Alektiar, KM; Boland, PJ; Healey, JH; La, TH; Laquaglia, MP; Meyers, PA; Wexler, LH; Wolden, SL | 1 |
| Danilatou, V; Kalmanti, M; Mantadakis, E; Papadhimitriou, S; Paterakis, G; Stiakaki, E | 1 |
| Fujinami, K; Maruta, I; Miura, T; Osada, Y; Takizawa, A; Tanaka, M | 1 |
| Apostolidis, I; Arvanitopoulou, E; Asprogeraka, T; Bakiri, M; Giannakoulas, N; Kotsianidis, I; Marinakis, T; Matsouka, P; Pagoni, M; Papaioannou, M; Skandali, A; Spanoudakis, E; Tsatalas, K; Viniou, N; Yataganas, X; Zikos, P | 1 |
| Al-Jefri, A; Al-Mahr, M; Al-Seraihi, A; Ayas, M; Belgaumi, A; El-Solh, H; Elhassan, I | 1 |
| Antoneli, CB; Arias, VE; Chojniak, MM; Novaes, PE; Ribeiro, Kde C; Sakamoto, LH | 1 |
| Classen, J; Dieckmann, KP; Gertenbach, U; Hahn, E; Loy, V; Ruwe, M; Souchon, R; Stambolis, C | 1 |
| Bedano, PM; Bonnin, J; Einhorn, LH | 1 |
| Kotani, T; Nakamura, Y; Ueda, M; Yamaguchi, M | 1 |
| Chan, GC; Cheuk, DK; Chiang, AK; Ha, SY; Lau, YL; Shek, TW | 1 |
| Arpaci, F; Ataergin, S; Cetin, T; Gunhan, O; Kaya, A; Kaya, T | 1 |
| Askin, FB; Bhatia, S; Burden, L; Chen, Z; Dickman, PS; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Perlman, EJ; Rausen, AR; Robison, LL; Vietti, TJ | 1 |
| Andrèsen, S; Avalos, B; Bolwell, B; Copelan, E; Elder, P; Farag, S; Kalaycio, M; Lin, T; Marcucci, G; Penza, S; Pohlman, B; Sobecks, R; Wadehra, N | 1 |
| Ben Arush, MW; Eran, A; Guilburd, J; Postovsky, S; Vlodavsky, E | 1 |
| Azarova, AM; Lau, JY; Lin, CP; Liu, LF; Lyu, YL; Tsai, YC; Wang, JC | 1 |
| Diehl, V; Fuchs, M | 1 |
| Brand, R; Dreger, P; Michallet, M | 1 |
| Bouffet, E; Fukushima, S; Katsuki, H; Shigemori, M; Terasaki, M | 1 |
| Fefer, A; Fisher, RI; Forman, SJ; Leblanc, M; Nademanee, AP; Petersdorf, SH; Press, OW; Stiff, PJ; Thompson, JA; Unger, JM | 1 |
| Briones, J; Camós, M; Colomo, L; Escoda, L; Espinosa, I; Estany, C; Gutiérrez-García, G; López-Guillermo, A; Martínez, S; Martino, R; Mercadal, S; Montserrat, E; Pedro, C; Ribera, JM; Xicoy, B | 1 |
| Affolter, A; Ahmed, M; Marais, R; Nutting, CM; Pritchard-Jones, K; Sharma, AK; Thomas, V; Venkitaraman, R | 1 |
| Advani, SH; Badrinath, Y; Bajpai, S; Gladstone, B; Kapoor, G; Nair, CN | 1 |
| Bonfante, V; Castellani, MR; Devizzi, L; Negretti, E; Santoro, A; Soncini, F; Villani, F; Viviani, S; Zanini, M; Zucali, R | 1 |
| Carpentier, AF; Chantelard, JV; Henin, D; Poisson, M | 1 |
| Andrews, R; Begent, RH; Boshoff, C; Holden, L; Newlands, ES; Oliver, RT; Ong, J; Rustin, GJ; Skelton, M | 1 |
| Cooper, DL; Flynn, SD; Reale, MA; Strair, RK; Yen, Y | 1 |
| Kaya, H; Kumabashiri, I; Matsuda, T; Nakamura, S; Ohtake, S; Yamazaki, H | 1 |
| Behm, FG; Boyett, JM; Hancock, ML; Krance, RA; Mahmoud, HH; Pui, CH; Raimondi, SC; Relling, MV; Ribeiro, RC; Sandlund, JT | 1 |
| Anastasi, J; Hayashi, Y; McGavran, L; Nucifora, G; Roulston, D; Rowley, JD; Rudinsky, R; Tsuchida, M; Zeleznik-Le, N | 1 |
| Amadori, S; Avvisati, G; Cedrone, M; Cimino, G; Mancini, F; Mandelli, F; Moleti, ML; Testi, AM; Todisco, E | 1 |
| Beyer, J; Bokemeyer, C; Kuczyk, MA; Schmoll, HJ; Siegert, W | 1 |
| Breeden, ES; Einhorn, LH; Loehrer, PJ; Nichols, CR; Williams, SD | 1 |
| Bajorin, DF; Bosl, GJ; Motzer, RJ; Murphy, B; Rodriguez, E | 1 |
| Felix, CA; Hosler, MR; Lange, BJ; Masterson, M; Wilson, AE; Winick, NJ | 1 |
| Bokemeyer, C; Schmoll, HJ | 1 |
| Burris, H; Grunberg, SM; Livingston, R | 1 |
| Baruchel, A; Berger, R; Daniel, MT; Derré, J; Hillion, J; Le Coniat, M; Leblanc, T | 1 |
| Fujita, N; Goto, H; Inaba, T; Moriguchi, T; Seto, M; Shimazaki, C; Tatsumi, T; Ueda, R; Yamagata, N; Yamamoto, K | 1 |
| Castel, V; Esquembre, C; Ferrís, J; Lopez-Andrew, JA; Senent, ML; Verdeguer, A | 1 |
| Ishizaki, T; Itoyama, T; Kuriyama, K; Nakamura, H; Sadamori, N; Soda, H; Tomonaga, M; Yamada, Y; Yoshida, Y | 1 |
| Crist, WM; Pratt, CB; Pui, CH; Rivera, GK; Santana, VM | 1 |
| Iida, H; Iida, M; Kodera, Y; Minami, S; Seto, M; Sugihara, T; Suzuki, R; Taji, H; Ueda, R; Yamamoto, K | 1 |
| Gazdar, AF; Ghosh, B; Johnson, BE; Kramer, BS; Minna, JD; Mitsudomi, T; Mulshine, JL; Pass, H; Phelps, R; Shaw, GL | 1 |
| Kumar, L | 1 |
| Evans, WE; McLeod, HL | 1 |
| Itoyama, S; Kinoshita, K; Masunaga, A; Seki, H; Sugawara, I; Takada, S; Takagi, A; Takeda, S | 1 |
| Donaldson, SS; Ensign, LG; Heyn, R; Khan, F; Maurer, HM; Ruymann, F; Smith, MA; Vietti, T | 1 |
| Barnett, MJ; Bredeson, CN; Dalal, BI; Horsman, DE; Phillips, GL; Ragaz, J | 1 |
| Fujii, M; Kumamoto, T; Okamoto, M; Okamura, A; Saitoh, Y; Toyoda, T; Umemoto, M; Yonezu, S | 1 |
| Andersson, M; Daugaard, G; Ersbøll, J; Hansen, SW; Hou-Jensen, K; Larsen, SO; Nielsen, D; Pedersen-Bjergaard, J; Philip, P; Sigsgaard, TC | 1 |
| Amess, J; Bower, M; Evans, GA; Gibbons, B; Lister, TA; Parry, P; Young, BD | 1 |
| Bowman, WP; Croce, CM; Felix, CA; Lange, BJ; Negrini, M; Winick, NJ | 1 |
| Alberto, P; Beris, P; Cabrol, C; Jotterand Bellomo, M; Mermillod, B; Zulian, GB | 1 |
| Borowitz, MJ; Bowman, WP; Buchanan, GR; Jacaruso, D; Kamen, BA; McKenna, RW; Schneider, NR; Shuster, JJ; Winick, NJ | 1 |
| Akatsuka, J; Furukawa, T; Nakazawa, S; Nishimura, K; Ohira, M; Okawa, Y; Sugita, K; Tsuchida, M | 1 |
| Cazenave, L; Gehan, E; Heyn, R; Khan, FM; Maurer, HM; Rubinstein, L; Smith, MA; Ungerleider, RS | 1 |
| Whitlock, JA | 1 |
| Broeker, PL; Pomykala, H; Rowley, JD; Super, HG; Tanabe, S; Thirman, MJ; Yonebayashi, Y; Zeleznik-Le, N | 1 |
| Cleary, ML; Davis, RE; Kamel, OW; Soslow, RA; Warnke, RA | 1 |
| Fujioka, S; Kato, K; Tomono, H | 1 |
| Deguchi, S; Fujita, M; Honda, K; Kikuchi, T; Miyata, A | 1 |
| Fukuda, H; Hyouchi, N; Ishiwata, D; Kamai, T; Masuda, H; Okuno, T; Tachibana, Y; Touma, T; Yonese, J | 1 |
| Flaherty, L; Katato, K; Varterasian, M | 1 |
| Joel, S | 1 |
| Bagshawe, KD; Foskett, M; Fuller, S; Hiscox, JG; Holden, L; Lutz, JM; Newlands, ES; Rustin, GJ; Short, D | 1 |
| Fujita, S; Hasegawa, A; Hasegawa, H; Hato, T; Ninomiya, H; Takada, K; Yanagisawa, K; Yasukawa, M | 1 |
| Cooper, DL; Levy, A; Salloum, E; Tallini, G | 1 |
| Ashihara, E; Fujita, N; Goto, H; Hatta, T; Hirai, H; Inaba, T; Kikuta, T; Nakagawa, M; Shimazaki, C; Sudo, Y; Sumikuma, T; Yamagata, N | 1 |
| Chen, CL; Fuscoe, JC; Liu, Q; Mahmoud, HH; Pui, CH; Relling, MV | 1 |
| Azar, N; Binet, JL; Boccaccio, C; Charlotte, F; Gabarre, J; Gentilini, M; Gonzalez, H; Jouan, M; Leblond, V; Sutton, L | 1 |
| Boesen, AM; de Nully Brown, P; Grønbaek, K; Hansen, OP; Hippe, E; Hoffmann, T; Jensen, MK; Pedersen-Bjergaard, J; Storm, HH; Thorling, K | 1 |
| Dearnaley, DP; Fisher, C; Horwich, A; Huddart, R; Husband, J; Nicholls, J; Norman, A; Paluchowska, B | 1 |
| Droste, JH; Hoekstra, HJ; Schraffordt Koops, H; Sleijfer, DT; van Basten, JP; van Driel, MF | 1 |
| Becton, DL; Sawyer, JR; Saylors, RL; Stine, KC | 1 |
| Horibe, K; Kudo, K; Naoe, T; Ohno, R; Yoshida, H | 1 |
| Hayashi, M; Ishimori, S; Kimura, K; Tabata, M; Tamada, T; Tsuburaya, T | 1 |
| Brøndum-Nielsen, K; Johansson, B; Karle, H; Pedersen-Bjergaard, J | 1 |
| Ellison, DW; Katapodis, O; Mead, GM; O'Callaghan, AM; Theaker, JM | 1 |
| Kita, K; Miwa, H; Mizuno, T; Morita, K; Nishikawa, M; Shiku, H; Suzuki, H; Tanaka, I | 1 |
| Behm, FG; Boyett, JM; Evans, WE; Nemec, J; Pui, CH; Relling, MV; Yanishevski, Y | 1 |
| Enblad, G; Glimelius, B; Gustavsson, A; Hagberg, H | 1 |
| Asami, K; Eguchi, H; Hatae, Y; Hirota, T; Iwai, A; Katano, N; Koizumi, S; Kono, Y; Matusita, T; Miyawaki, T; Mugisima, H; Nakayama, M; Nisikawa, K; Osima, K; Sekine, I; Simokawa, T; Suzumiya, J; Tanaka, A; Tsuchiya, T; Tsurusawa, M; Utumi, J; Yamamoto, Y; Yamamura, Y; Yanase, T; Yokota, S | 1 |
| Adachi, M; Horiike, S; Huang, CL; Ieki, Y; Konaka, Y; Miyake, M; Onishi, R; Taki, T; Yagita, M | 1 |
| Horibe, K; Kiyoi, H; Kudo, K; Naoe, T; Numata, S; Yoshida, H | 1 |
| Bajorin, D; Cheung, NK; Heller, G; Kramer, K; Kushner, BH; Meyers, PA; Polyak, T; Wollner, N | 1 |
| Beyer, J; Biron, P; Bokemeyer, C; Droz, JP; Fléchon, A; Harstrick, A; Hartmann, JT; Kanz, L; Kollmannsberger, C; Kuczyk, M; Schmoll, HJ; Schöffski, P | 1 |
| Astori, C; Bernasconi, C; Bernasconi, P; Lazzarino, M; Orlandi, E | 1 |
| Bruntsch, U; Diehl, V; Dölken, G; Engert, A; Franklin, J; Hasenclever, D; Koch, P; Lathan, B; Loeffler, M; Müller, U; Pfreundschuh, M; Rüffer, U; Schalk, KP; Schmitz, N; Schwieder, G; Sieber, M; Tesch, H; Tirier, C; Worst, P; Wulf, G | 1 |
| Murray, TG; O'Brien, JM; Scott, IU; Toledano, S | 1 |
| Anderson, JR; Arthur, D; Catalano, PJ; Freidlin, B; Heyn, R; Khayat, A; Krailo, M; Land, VJ; Miser, J; Rubinstein, L; Shuster, J; Smith, MA; Vena, D | 1 |
| Curti, A; Lemoli, RM; Leopardi, G; Motta, MR; Rizzi, S; Testoni, N; Tura, S; Visani, G | 1 |
| Ikeda, K; Ikeda, T; Kawakami, K; Sasaki, K; Takahara, J | 1 |
| Brugger, W; Engelhardt, R; Fetscher, S; Frommhold, H; Hasse, J; Kanz, L; Lange, W; Mertelsmann, R | 1 |
| Behnisch, W; Göbel, U; Hilgenfeld, E; Schneider, DT; Schwabe, D; Wessalowski, R; Zoubek, A | 1 |
| Devereux, S; Goldstone, AH; Gregory, W; Hancock, B; Harrison, CN; Hoskin, P; Hudson, GV; Linch, DC; MacMillan, AK; Milligan, D; Newland, AC; Winfield, D | 1 |
| Brewer, M; Gershenson, DM; Herzog, CE; Mitchell, MF; Silva, EG; Wharton, JT | 1 |
| Andoh, T | 1 |
| de Montpreville, V; Munck, JN; Regnard, JF; Terrier, P; Ulusakarya, A | 1 |
| Hayakawa, A; Kosaka, Y; Nakamura, H; Piao, JH; Sano, K | 1 |
| Bourhis, JH; Brice, P; Brousse, N; Decaudin, D; Gisselbrecht, C; Haioun, C; Morel, P; Quesnel, B; Souleau, B; Van Hoof, A | 1 |
| Arber, DA; Bhatia, R; Bhatia, S; Forman, SJ; Fung, H; Kashyap, A; Krishnan, A; Molina, A; Nademanee, A; Niland, JC; O'Donnell, MR; Parker, PA; Slovak, ML; Sniecinski, I; Snyder, DS; Spielberger, R; Stein, A | 1 |
| Eden, OB; Gibson, B; Hann, I; Hill, F; Kinsey, S; Lilleyman, J; Mitchell, C; Richards, S; Vora, A | 1 |
| Berglund, A; Carlson, K; Enblad, G; Glimelius, B; Hagberg, H | 1 |
| Butch, AW; Flick, JT; Pappas, AA; Yeh, YA | 1 |
| Bacci, G; Bertoni, F; Campanacci, M; Casadei, R; Fabbri, N; Ferrari, S; Forni, C; Longhi, A; Picci, P; Ruggieri, P; Versari, M | 1 |
| Cordone, I; De Cuia, R; Fenu, S; Guerrisi, V; Mandelli, F; Mauro, FR; Meloni, G; Pescarmona, E; Proia, A; Reato, G | 1 |
| Douglas, R; Michael, B; Nabil, S; Thomas, F | 1 |
| Ahmed, T; Feldman, EJ; Kancherla, R; Liu, D; Papageorgio, C; Pozzuoli, M; Seiter, K; Sreekantaiah, C; Weisberger, J; Weiss, M | 1 |
| Antin, J; Ault, K; Elias, A; Ibrahim, J; Khurshid, A; Mauch, P; Wheeler, C | 1 |
| Glimelius, B; Kimby, E; Nygren, P | 1 |
| Blair, IA; Felix, CA; Lo Nigro, L; Lovett, BD; Megonigal, MD; Nowell, PC; Osheroff, N; Rappaport, EF; Williams, WR; Zheng, N | 1 |
| Castello, MA; Maurizi, P; Schiavetti, A; Varrasso, G | 1 |
| Arai, K; Fukayama, M; Imashuku, S; Ito, E; Kitazawa, J; Yokoyama, M | 1 |
| Nishimura, S; Sato, T; Ueda, H; Ueda, K | 1 |
| Hara, T; Kanemura, N; Moriwaki, H; Naito, T; Sawada, M; Tsurumi, H; Yamada, T | 1 |
| De Giorgi, U; Marangolo, M; Papiani, G; Rosti, G | 1 |
| Ahrens, S; Aulitzky, WE; Dunst, J; Fölsch, UR; Göbel, U; Harms, D; Hense, HW; Henze, G; Jürgens, H; Kremens, B; Lehnert, M; Niemeyer, C; Paulussen, M; Reiter, A; Taeger, D; Voûte, PA; Wagner, A; Zoubek, A | 1 |
| Bernis, C; de La Cámara, R; Osorio, S | 1 |
| Nakahara, I; Nishikawa, M; Sugimoto, K | 1 |
| Kakishita, E; Mori, A; Okada, M; Okamoto, T; Takatsuka, H; Wakae, T | 1 |
| Arush, MW; Beck, D; Ben-Izhak, O; Postovsky, S | 1 |
| Ballard, ET; Huang, FS; Stern, LE; Warner, BW; Zwerdling, T | 1 |
| Hibi, S; Imashuku, S; Ito, E; Kitazawa, J; Kuriyama, K; Morimoto, A; Teramura, T | 1 |
| Broxson, EH; Dole, MG; Dunkel, IJ; Filippa, DA; George, D; Heath, JA; Lyden, D | 1 |
| Brito, G; Fernandez, T; Klumb, C; Land, MG; Maradei, S; Otero, L; Pombo-de-Oliveira, MS; Silva, ML; Veith, M | 1 |
| Barbui, T; Chang, J; Cowan, RA; Crowther, D; Deakin, DP; Dunlop, DJ; Gupta, RK; James, RD; Lister, TA; Lucie, NP; Radford, JA; Rohatiner, AZ; Rossi, A; Ryder, WD; Shamash, J; Wilkinson, PM | 1 |
| Bokemeyer, C; Fonatsch, C; Freund, M; Rieder, H; Schmoll, HJ | 1 |
| Arnott, S; D'Ardenne, J; Ganesan, TS; Lister, TA; Oza, A; Perry, N; Shand, WS; Stansfeld, AG; Wrigley, PF | 1 |
| Alberto, P; Mermillod, B; Zulian, GB | 1 |
| Kobayashi, K; Ratain, MJ | 1 |
| Behm, FG; Evans, WE; Hancock, ML; Head, DR; Mahmoud, MH; Pui, CH; Raimondi, SC; Ribeiro, RC; Rivera, GK; Sandlund, JT | 1 |
37 review(s) available for etoposide and Cancer, Second Primary
| Article | Year |
|---|---|
Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease Progression; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasms, Second Primary; Prednisone; Procarbazine; Progression-Free Survival; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stem Cell Transplantation; Time Factors; Transplantation, Autologous; Vinblastine; Vincristine; Young Adult | 2020 |
Limited-stage Hodgkin lymphoma: optimal chemotherapy and the role of radiotherapy.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Leukemia, Radiation-Induced; Neoplasm Staging; Neoplasms, Second Primary; Patient Selection; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine | 2013 |
[Report of a case with secondary acute promyelocytic leukemia after therapy for hemophagocytic lymphohistiocytosis and review of literature].
Topics: Acute Disease; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Daunorubicin; Epstein-Barr Virus Infections; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Lymphohistiocytosis, Hemophagocytic; Male; Neoplasms, Second Primary; Risk Assessment; Treatment Outcome; Tretinoin | 2013 |
Reproductive outcomes after hydatiform mole and gestational trophoblastic neoplasia.
Topics: Antineoplastic Agents; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Incidence; Leukemia, Myeloid; Menopause, Premature; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Stillbirth; Uterine Neoplasms | 2015 |
Paraspinal synovial sarcoma as an unusual postradiation complication in pediatric abdominal neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 18; Chromosomes, Human, X; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Lumbar Vertebrae; Mechlorethamine; Muscle Neoplasms; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neuroblastoma; Oncogene Proteins, Fusion; Remission Induction; Retroperitoneal Neoplasms; Sarcoma, Synovial; Spinal Stenosis; Translocation, Genetic; Vincristine | 2008 |
Development of testicular alpha-fetoprotein-secreting germ cell tumor 3 years after treatment of intracranial lesion identified as non-secreting germ cell tumor on the basis of clinical data--case report.
Topics: alpha-Fetoproteins; Carboplatin; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Etoposide; Follow-Up Studies; Hemianopsia; Humans; Magnetic Resonance Imaging; Male; Neoplasm Proteins; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Orchiectomy; Supratentorial Neoplasms; Testicular Neoplasms; Young Adult | 2008 |
Is BEACOPP better than ABVD?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Forecasting; Hodgkin Disease; Humans; Infertility; Male; Multicenter Studies as Topic; Neoplasms, Second Primary; Patient Selection; Prednisone; Procarbazine; Remission Induction; Survival Rate; Treatment Outcome; Vinblastine; Vincristine | 2007 |
Bilateral Wilms' tumors: single-center experience with 22 cases and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Egypt; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Mesna; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Nephrectomy; Retrospective Studies; Treatment Outcome; Vincristine; Wilms Tumor | 2010 |
Intensified therapy followed by autologous stem-cell transplantation (ASCT) versus conventional therapy as first-line treatment of follicular lymphoma: a meta-analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Follicular; Male; Melphalan; Middle Aged; Neoplasms, Second Primary; Prednisone; Recombinant Proteins; Remission Induction; Survival Analysis; Teniposide; Transplantation, Autologous; Treatment Outcome; Vincristine; Whole-Body Irradiation | 2013 |
[Therapy-related acute myeloid leukemia following double autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Monocytic, Acute; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasms, Second Primary | 2002 |
Testis conserving chemotherapy in germ cell cancer: its potential to increase understanding of the biology and treatment of carcinoma-in-situ.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma in Situ; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Orchiectomy; Testicular Neoplasms; Testis; Time Factors; Vinblastine | 2003 |
[A case of organ sparing surgery for metachronous bilateral testicular tumor with maintaining testicular function].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Embryonal; Cisplatin; Combined Modality Therapy; Etoposide; Fertility; Humans; Male; Neoplasms, Second Primary; Oligospermia; Orchiectomy; Seminoma; Teratoma; Testicular Neoplasms; Testis; Treatment Outcome | 2004 |
Analysis of treatment for small cell cancer of the bladder and report of three cases.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Biomarkers, Tumor; Bone Neoplasms; Carboplatin; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Deoxycytidine; Disease Progression; Etoposide; Gemcitabine; Humans; Life Tables; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasms, Second Primary; Prostatectomy; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Urinary Diversion | 2004 |
Recent advances in the treatment of testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Male; Neoplasm Staging; Neoplasms, Second Primary; Prognosis; Risk Factors; Seminoma; Testicular Neoplasms | 2005 |
Trilateral retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease Progression; Etoposide; Eye Enucleation; Eye Neoplasms; Fatal Outcome; Female; Humans; Idarubicin; Ifosfamide; Male; Methotrexate; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Neoplastic Syndromes, Hereditary; Pinealoma; Prognosis; Retinoblastoma; Vincristine | 2007 |
Parotid acinar cell carcinoma in a long-term survivor of childhood acute lymphoblastic leukemia.
Topics: Adenoma, Sweat Gland; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carcinoma, Acinar Cell; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Male; Mercaptopurine; Methotrexate; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Parotid Neoplasms; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Survivors; Sweat Gland Neoplasms; Vincristine; Whole-Body Irradiation | 2008 |
Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Heart Diseases; Hodgkin Disease; Humans; Infertility; Lung Diseases; Mechlorethamine; Multicenter Studies as Topic; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Risk; Survival Rate; Vinblastine; Vincristine | 2007 |
Autologous stem cell transplantation for chronic lymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Dexamethasone; Etoposide; Evidence-Based Medicine; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Melphalan; Neoplasm, Residual; Neoplasms, Second Primary; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation | 2007 |
Therapy-related acute leukemia associated with t(11q23) after primary acute myeloid leukemia with t(8;21): a report of two cases.
Topics: Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cell Lineage; Child; Child, Preschool; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Cytarabine; Enzyme Inhibitors; Etoposide; Fatal Outcome; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Mitoxantrone; Neoplasms, Second Primary; Oncogenes; Topoisomerase II Inhibitors; Translocation, Genetic | 1995 |
Treatment of testicular cancer and the development of secondary malignancies.
Topics: Antineoplastic Agents; Etoposide; Germinoma; Hodgkin Disease; Humans; Leukemia; Leukemia, Radiation-Induced; Male; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Testicular Neoplasms | 1995 |
Secondary acute promyelocytic leukemia in a child treated with epipodophyllotoxins.
Topics: Bone Neoplasms; Child; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Male; Neoplasms, Second Primary; Pelvic Bones; Sarcoma, Ewing; Teniposide | 1994 |
Acute myeloid leukaemia with t(9;11)(p22;q23) in a patient treated for adult T cell leukaemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Cyclophosphamide; Etoposide; Humans; Karyotyping; Leukemia, Myeloid, Acute; Leukemia, T-Cell; Male; Neoplasms, Second Primary; Translocation, Genetic | 1994 |
Epipodophyllotoxins in the treatment of childhood cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytarabine; Etoposide; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Neoplasms; Neoplasms, Second Primary; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1994 |
Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistance.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Drug Resistance; Etoposide; Humans; Isotretinoin; Lung Neoplasms; Neoplasms, Second Primary; Neoplastic Stem Cells; Oncogenes; Phenotype; Tumor Cells, Cultured | 1994 |
Clinical pharmacokinetics and pharmacodynamics of epipodophyllotoxins.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Resistance; Etoposide; Humans; Leukemia; Neoplasms; Neoplasms, Second Primary; Teniposide; Topoisomerase II Inhibitors | 1993 |
[A case of secondary leukemia in anaplastic seminoma patient treated with long-term chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasms, Second Primary; Podophyllotoxin; Seminoma; Testicular Neoplasms | 1996 |
The clinical pharmacology of etoposide: an update.
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Drug Administration Schedule; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Humans; Neoplasms; Neoplasms, Second Primary | 1996 |
Burkitt's lymphoma-leukemia in patients treated for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Follicular; Mechlorethamine; Mediastinal Neoplasms; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Procarbazine; Spinal Neoplasms; Thoracic Vertebrae; Vinblastine; Vincristine | 1996 |
[Three cases of secondary acute myeloid leukemia after long-term treatment with oral etoposide].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Small Cell; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Neoplasms, Second Primary | 1996 |
The growing teratoma syndrome in a nongerminomatous germ cell tumor of the pineal gland: a case report and review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Diagnosis, Differential; Endodermal Sinus Tumor; Etoposide; Humans; Leucovorin; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Pineal Gland; Syndrome; Teratoma; Vincristine | 1997 |
Etoposide-related acute promyelocytic leukemia.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Base Sequence; Child; Child, Preschool; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Etoposide; Female; Humans; Infant; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Molecular Sequence Data; Neoplasm Proteins; Neoplasms, Second Primary; Oncogene Proteins, Fusion; Topoisomerase II Inhibitors | 1998 |
Extraskeletal osteosarcoma of the mediastinum after treatment of a mediastinal germ-cell tumor.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Etoposide; Fatal Outcome; Follow-Up Studies; Germinoma; Humans; Male; Mediastinal Neoplasms; Neoplasm, Residual; Neoplasms, Second Primary; Osteosarcoma; Teratoma | 1999 |
Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 11; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cytarabine; Disease Progression; Disease-Free Survival; Enzyme Inhibitors; Etoposide; Female; Humans; Idarubicin; Incidence; Karyotyping; Leukemia, Myeloid; Life Tables; Male; Middle Aged; Mitoxantrone; Myelodysplastic Syndromes; Neoplasm Proteins; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Topoisomerase II Inhibitors; Treatment Outcome; Tretinoin | 2001 |
A systematic overview of chemotherapy effects in acute myeloid leukaemia.
Topics: Acute Disease; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Humans; Leukemia, Myeloid; Middle Aged; Mitoxantrone; Neoplasms, Second Primary; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome | 2001 |
The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Etoposide; Europe; Forecasting; Gastrointestinal Diseases; Germinoma; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Ifosfamide; Kidney Diseases; Male; Multicenter Studies as Topic; Neoplasms, Second Primary; Paclitaxel; Prognosis; Randomized Controlled Trials as Topic; Salvage Therapy; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2002 |
Bilateral metachronous germinoma of the basal ganglia occurring long after total removal of a mature pineal teratoma: case report.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Basal Ganglia Diseases; Brain Neoplasms; Carboplatin; Child; Combined Modality Therapy; Etoposide; Germinoma; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Second Primary; Pineal Gland; Teratoma | 2002 |
Secondary thyroid carcinoma after treatment for clear cell carcinoma of the uterus: case report and review of the literature.
Topics: Adenocarcinoma, Clear Cell; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Lymphatic Metastasis; Mesna; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Thyroid Neoplasms; Thyroidectomy; Uterine Neoplasms; Vincristine | 2001 |
34 trial(s) available for etoposide and Cancer, Second Primary
| Article | Year |
|---|---|
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
Topics: Adult; Allografts; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Consolidation Chemotherapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Humans; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Myeloablative Agonists; Neoplasms, Second Primary; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prospective Studies; Risk; Transplantation Conditioning; Transplantation, Autologous; Vincristine | 2021 |
Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Germany; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy; Radiotherapy Dosage; Survival Rate; Time Factors; Vinblastine; Vincristine; Young Adult | 2017 |
A Phase III trial comparing irinotecan and cisplatin with etoposide and cisplatin in adjuvant chemotherapy for completely resected pulmonary high-grade neuroendocrine carcinoma (JCOG1205/1206).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Clinical Protocols; Disease-Free Survival; Etoposide; Female; Humans; Incidence; Irinotecan; Japan; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Patient Selection; Survival Analysis; Treatment Outcome | 2014 |
Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Orchiectomy; Testicular Neoplasms; Time; Young Adult | 2015 |
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Italy; Kaplan-Meier Estimate; Lomustine; Male; Melphalan; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2016 |
Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Eye Neoplasms; Female; Humans; Incidence; Infant; Infant, Newborn; Male; Neoplasms, Second Primary; Retinoblastoma; Retrospective Studies; Survival Rate; Vincristine | 2012 |
Fludarabine and cytarabine in patients with relapsed acute myeloid leukemia refractory to initial salvage therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Cytarabine; Etoposide; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Karyotype; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasms, Second Primary; Recurrence; Remission Induction; Salvage Therapy; Vidarabine | 2012 |
A phase I and pharmacodynamic study of sequential topotecan and etoposide in patients with relapsed or refractory acute myelogenous and lymphoblastic leukemia.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow; Chemical and Drug Induced Liver Injury; DNA Topoisomerases, Type II; Drug Administration Schedule; Drug Resistance, Neoplasm; Enzyme Induction; Enzyme Inhibitors; Etoposide; Female; Gastrointestinal Diseases; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Middle Aged; Neoplasm Proteins; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Salvage Therapy; Topoisomerase I Inhibitors; Topotecan | 2003 |
Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment.
Topics: Adolescent; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Infant; Male; Myelodysplastic Syndromes; Neoplasms, Second Primary; Placebos; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2003 |
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Leukemia; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Survival Analysis; Vinblastine; Vincristine | 2003 |
Oral etoposide for recurrent/progressive sarcomas of childhood.
Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Disease Progression; Etoposide; Female; Humans; Male; Neoplasms, Second Primary; Palliative Care; Recurrence; Remission Induction; Sarcoma; Survival Rate; Treatment Outcome | 2004 |
Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation.
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Incidence; Leukemia; Lymphoma; Male; Middle Aged; Neoplasms, Second Primary; Neural Tube Defects; Peripheral Blood Stem Cell Transplantation; Probability; Transplantation, Autologous | 2004 |
High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: an effective regimen with low morbidity and mortality.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Second Primary; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Salvage Therapy; Survival Analysis; Transplantation, Autologous | 2005 |
A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer and Leukemia Group B Study (9235).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cranial Irradiation; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Survival Analysis; Tamoxifen | 2005 |
Addition of cyclosporin-A to chemotherapy in secondary (post-MDS) AML in the elderly. A multicenter randomized trial of the Leukemia Working Group of the Hellenic Society of Hematology.
Topics: Acute Disease; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Data Interpretation, Statistical; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Greece; Humans; Idarubicin; Infusions, Intravenous; Leukemia, Myeloid; Male; Middle Aged; Neoplasms, Second Primary; Remission Induction; Societies, Medical; Survival Analysis; Treatment Outcome | 2006 |
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Incidence; Infant; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Neural Tube Defects; Neuroectodermal Tumors, Primitive; Proportional Hazards Models; Risk; Sarcoma, Ewing; Vincristine | 2007 |
Pilot trial of the rate of response, safety, and tolerability of temozolomide and oral VP-16 in patients with recurrent or treatment-induced malignant central nervous system tumors.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Dacarbazine; Drug Therapy, Combination; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Neuroepithelial; Neoplasms, Second Primary; Pilot Projects; Temozolomide; Treatment Outcome | 2008 |
Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomiz
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Interleukin-2; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Second Primary; Peripheral Blood Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation | 2008 |
Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, T-Cell, Peripheral; Male; Melphalan; Middle Aged; Neoplasms, Second Primary; Peripheral Blood Stem Cell Transplantation; Prednisone; Remission Induction; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine | 2008 |
Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Risk Factors; Salvage Therapy; Vinblastine; Vincristine | 1994 |
L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Synergism; Etoposide; Humans; Infant; Karyotyping; Leukemia, Myeloid; Mercaptopurine; Methotrexate; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone | 1995 |
Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Extremities; Family Health; Female; Humans; Infant; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Meningeal Neoplasms; Myelodysplastic Syndromes; Neoplasms, Second Primary; Odds Ratio; Osteosarcoma; Rhabdomyosarcoma; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Risk Factors; Spinal Neoplasms | 1994 |
Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial.
Topics: Aclarubicin; Acute Disease; Adolescent; Adult; Age Factors; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Myeloid; Male; Middle Aged; Neoplasms, Second Primary; Recurrence; Remission Induction; Survival Rate; Survivors | 1997 |
[Treatment of children with non-Hodgkin's lymphoma with CCLSG NHL 855/890 protocols long-term outcome and incidence of secondary malignancies].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Hydrocortisone; Infant; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Neoplasms, Second Primary; Prednisolone; Remission Induction; Treatment Outcome; Vincristine | 1998 |
High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Leukemia; Male; Myelodysplastic Syndromes; Neoplasms; Neoplasms, Second Primary; Prospective Studies; Risk Factors; Vincristine | 1998 |
Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Leukemia; Male; Middle Aged; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Recombinant Proteins; Remission Induction; Survival Rate; Treatment Outcome; Vincristine | 1998 |
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasms, Second Primary | 1999 |
Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Mantle-Cell; Male; Melphalan; Middle Aged; Neoplasms, Second Primary; Recurrence; Survival Rate; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation | 2000 |
Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infections; Male; Methotrexate; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Proportional Hazards Models; Remission Induction; Risk; Survival Analysis; Thioguanine; Treatment Outcome; Vincristine | 2000 |
Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Extremities; Female; Fertility; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Osteosarcoma; Patient Compliance; Plastic Surgery Procedures; Postoperative Complications; Radiography; Reoperation; Survival Rate | 2000 |
Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Europe; Humans; Ifosfamide; Incidence; Infant; Middle Aged; Neoplasms, Second Primary; Prospective Studies; Radiotherapy Dosage; Sarcoma, Ewing; Vincristine | 2001 |
Risk of etoposide-related acute myeloid leukemia in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Epstein-Barr Virus Infections; Etoposide; Female; Follow-Up Studies; Histiocytosis, Non-Langerhans-Cell; Humans; Infant; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Risk Assessment | 2002 |
ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Incidence; Italy; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisolone; Procarbazine; Prognosis; Treatment Outcome; United Kingdom; Vinblastine; Vincristine | 2002 |
Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Humans; Leukemia, Myeloid; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Risk Factors; Teniposide | 1991 |
155 other study(ies) available for etoposide and Cancer, Second Primary
| Article | Year |
|---|---|
Delivering Chemotherapy to a Metastatic Poor Risk Testicular Cancer Patient on Hemodialysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Renal Dialysis; Testicular Neoplasms | 2022 |
Outcomes of Pediatric Patients With Metastatic Ewing Sarcoma Treated With Interval Compression.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Neoplasms, Second Primary; Sarcoma, Ewing; Vincristine | 2023 |
A report on second neo-plasms in seven children with solid tumors.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasms, Second Primary; Neuroblastoma; Retrospective Studies; Rhabdomyosarcoma; Vincristine | 2022 |
Therapy-related acute myeloid leukemia secondary to histiocytic sarcoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Neoplasms, Second Primary; Polyethylene Glycols; Prednisone; Sarcoma; Vincristine | 2021 |
Double recurrence of double cancers: Rhabdomyosarcoma and secondary AML.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Fatal Outcome; Humans; Ifosfamide; Japan; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Rhabdomyosarcoma, Alveolar | 2020 |
Unique evolution of angioimmunoblastic T cell lymphoma to Epstein-Barr virus-positive plasma cell myeloma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Herpesvirus 4, Human; Humans; Lenalidomide; Lymphoma, T-Cell; Male; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prednisolone; Vincristine | 2020 |
Small lymphocytic lymphoma secondary to young patient with a history of classical Hodgkin Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Neoplasms, Second Primary; Prednisone; Procarbazine; Vinblastine; Vincristine | 2022 |
Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Clinical Trials, Phase II as Topic; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Prognosis; Randomized Controlled Trials as Topic; Survival Rate; Vincristine; Young Adult | 2022 |
[Neuroendocrine prostate cancer].
Topics: Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Chromogranin A; Cisplatin; Etoposide; Humans; Male; Neoplasms, Second Primary; Neuroendocrine Tumors; Phosphopyruvate Hydratase; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Survival Rate | 2017 |
Partial restoration of CD20 protein expression and rituximab sensitivity after treatment with azacitidine in CD20-negative transformed diffuse large B cell lymphoma after using rituximab.
Topics: Antigens, CD20; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bendamustine Hydrochloride; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Molecular Targeted Therapy; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednisone; Rituximab; Vincristine | 2018 |
A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Cisplatin; Cohort Studies; Dysgerminoma; Endodermal Sinus Tumor; Etoposide; Female; Gynecologic Surgical Procedures; Humans; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Ovarian Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Progression-Free Survival; Proportional Hazards Models; Retrospective Studies; Teratoma; Treatment Outcome; Young Adult | 2019 |
Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Germany; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Survival Rate; Vincristine; Young Adult | 2014 |
After the treated mole.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Immunophenotyping; Leukemia, Myeloid, Acute; Methotrexate; Neoplasms, Second Primary; Pregnancy; Trophoblasts; Vincristine | 2014 |
Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Incidence; Kaplan-Meier Estimate; Menopause, Premature; Methotrexate; Middle Aged; Neoplasms, Second Primary; Odds Ratio; Pregnancy; Risk Assessment; Risk Factors; Uterine Neoplasms; Vincristine; Young Adult | 2015 |
High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Prednisone; Procarbazine; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine | 2016 |
Three cases of thyroid cancer following the diagnosis of testicular cancer: treatment-related complication or genetics?
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cancer Care Facilities; Carcinoma; Carcinoma, Papillary; Cisplatin; Etoposide; Humans; Male; Medical Records; Neoplasms, Second Primary; PTEN Phosphohydrolase; Scotland; Tertiary Care Centers; Testicular Neoplasms; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2016 |
Recurrent 'growing teratoma syndrome' in an adolescent girl with a history of ovarian immature teratoma: A case report.
Topics: Adolescent; Antineoplastic Agents; Biopsy; Cisplatin; Disease Management; Etoposide; Female; Humans; Lymph Nodes; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Second Primary; Omentum; Ovarian Neoplasms; Ovariectomy; Teratoma; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2016 |
Small cell carcinoma of the pyriform sinus successfully treated with concurrent chemo-radiotherapy: A case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemoradiotherapy; Cisplatin; Etoposide; Humans; Hypopharyngeal Neoplasms; Lung Neoplasms; Male; Neoplasms, Second Primary; Pyriform Sinus; Small Cell Lung Carcinoma | 2016 |
Second Malignant Neoplasms and Cause of Death in Patients With Germ Cell Cancer: A Danish Nationwide Cohort Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cohort Studies; Denmark; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Proportional Hazards Models; Risk Factors; Treatment Outcome | 2016 |
Ewing Sarcoma of the Bone With EWS/FLI1 Translocation After Successful Treatment of Primary Osteosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Femoral Neoplasms; Humans; Ifosfamide; Limb Salvage; Methotrexate; Neoplasms, Second Primary; Oncogene Proteins, Fusion; Osteosarcoma; Proto-Oncogene Protein c-fli-1; Remission Induction; RNA-Binding Protein EWS; Sarcoma, Ewing; Vincristine | 2017 |
Sequential development of peripheral t-cell lymphoma post immunochemotherapy of diffuse large B cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Cytarabine; Epstein-Barr Virus Infections; Etoposide; Gene Rearrangement; Genes, Immunoglobulin Heavy Chain; Herpesvirus 4, Human; Humans; Immunohistochemistry; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Neoplasms, Second Primary; Polymerase Chain Reaction; Prednisone; Radiotherapy, Adjuvant; Receptors, Antigen, T-Cell; Rituximab; Tomography, X-Ray Computed; Tongue | 2017 |
Mucoepidermoid carcinoma of the submandibular gland after chemotherapy in a child.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Busulfan; Carcinoma, Mucoepidermoid; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Image Processing, Computer-Assisted; Leukemia, Myeloid, Acute; Male; Neck Dissection; Neoplasms, Second Primary; Positron-Emission Tomography; Submandibular Gland Neoplasms; Thioguanine; Tomography, X-Ray Computed; Transplantation Conditioning | 2009 |
Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma.
Topics: Adrenal Gland Neoplasms; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Fluorouracil; Focal Nodular Hyperplasia; Granulocyte Colony-Stimulating Factor; Hepatectomy; Hepatoblastoma; Humans; Ifosfamide; Immunoglobulin G; Incidental Findings; Liver Neoplasms; Male; Melphalan; Mesna; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neuroblastoma; Radiotherapy, Adjuvant; Tomography, X-Ray Computed; Vincristine | 2008 |
Secondary leukemia in a child conceived using in vitro fertilization.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Cyclophosphamide; Dactinomycin; Etoposide; Fertilization in Vitro; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Rhabdomyosarcoma; Vincristine | 2008 |
Life-threatening conjunctival presentation of myeloid sarcoma.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Conjunctival Neoplasms; Cytarabine; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Middle Aged; Neoplasms, Second Primary; Sarcoma, Myeloid; Skin Neoplasms | 2008 |
Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Lymphoma, Non-Hodgkin; Melphalan; Middle Aged; Neoplasms, Second Primary; Retrospective Studies; Risk Factors; Salvage Therapy; Transplantation, Autologous; Whole-Body Irradiation; Young Adult | 2009 |
Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.
Topics: Antineoplastic Agents, Phytogenic; Child, Preschool; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Lymphohistiocytosis, Hemophagocytic; Male; Neoplasms, Second Primary | 2009 |
Small-cell lung cancer arising after chemotherapy for a patient with lymphoma of pulmonary mucosa-associated lymphoid tissue-a case report.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Cladribine; Etoposide; Fatal Outcome; Female; Humans; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Mucous Membrane; Neoplasms, Second Primary; Rituximab; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2009 |
Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednimustine; Prednisone; Procarbazine; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine | 2011 |
Ovarian involvement of epithelioid trophoblastic tumor: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Immunohistochemistry; Methotrexate; Neoplasms, Second Primary; Ovarian Neoplasms; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms | 2011 |
Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Lymphoma; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Risk Factors; Young Adult | 2012 |
Therapy-related acute myeloid leukemia following treatment with trabectedin for Ewing's sarcoma.
Topics: Adult; Antineoplastic Agents, Alkylating; Bone Neoplasms; Dioxoles; Etoposide; Fatal Outcome; Female; Gene Deletion; Gene Rearrangement; Humans; Leukemia, Myeloid, Acute; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Sarcoma, Ewing; Tetrahydroisoquinolines; Topoisomerase Inhibitors; Trabectedin; Young Adult | 2011 |
Therapy-associated secondary tumors in patients with non-germinomatous malignant germ cell tumors.
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Child, Preschool; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Combined Modality Therapy; Etoposide; Female; Glioblastoma; Hemangioma, Cavernous; Humans; Maintenance Chemotherapy; Male; Meningeal Neoplasms; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Prognosis; Survival Rate; Young Adult | 2011 |
Development of acute megakaryoblastic leukemia with isochromosome (12p) after a primary mediastinal germ cell tumor in Korea.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Chromosomes, Human, Pair 12; Cisplatin; Etoposide; Humans; Isochromosomes; Karyotyping; Leukemia, Megakaryoblastic, Acute; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Republic of Korea; Shock, Septic | 2011 |
Unexpected pancytopenia following treatment of acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chromosomes, Human, Pair 6; Chromosomes, Human, Pair 9; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Erythropoiesis; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Middle Aged; Neoplasms, Second Primary; Oncogene Proteins, Fusion; Pancytopenia; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Translocation, Genetic; Vincristine | 2012 |
Vaginal cancer following etoposide-containing chemotherapy for metastatic gestational trophoblastic tumour.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Etoposide; Female; Humans; Hydatidiform Mole; Lung Neoplasms; Middle Aged; Neoplasms, Second Primary; Pregnancy; Uterine Neoplasms; Vaginal Neoplasms | 2012 |
Model for MLL translocations in therapy-related leukemia involving topoisomerase IIβ-mediated DNA strand breaks and gene proximity.
Topics: Chromatin Immunoprecipitation; DNA Breaks, Double-Stranded; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Fluorescence; Humans; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Acute; Micronucleus Tests; Models, Biological; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Translocation, Genetic | 2012 |
Do transcription factories and TOP2B provide a recipe for chromosome translocations in therapy-related leukemia?
Topics: Anthracyclines; DNA Breaks, Double-Stranded; DNA Topoisomerases, Type II; DNA-Binding Proteins; Epirubicin; Etoposide; Humans; Leukemia; Mitoxantrone; Models, Genetic; Neoplasms, Second Primary; Poly-ADP-Ribose Binding Proteins; Translocation, Genetic | 2012 |
Probability of metachronous testicular cancer in patients with biopsy-proven intratubular germ cell neoplasia depends on first-time treatment of germ cell cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Germinoma; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Norway; Orchiectomy; Platinum Compounds; Radiotherapy, Adjuvant; Retrospective Studies; Risk; Testicular Neoplasms; Watchful Waiting | 2012 |
[Successful treatment with G-CSF and continuous infusion of low-dose cytarabine and etoposide for therapy-related acute myeloid leukemia developed during chemotherapy for malignant lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Cytarabine; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Leukemia, Myelomonocytic, Acute; Lymphoma, Non-Hodgkin; Male; Neoplasms, Second Primary; Remission Induction; Translocation, Genetic | 2002 |
Thalidomide paradoxical effect on concomitant multiple myeloma and myelodysplasia.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cell Division; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neoplastic Stem Cells; Peripheral Blood Stem Cell Transplantation; Thalidomide; Vincristine | 2002 |
A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bone Marrow Cells; Carmustine; Chromosome Aberrations; Chromosomes, Human, Pair 11; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Gene Rearrangement; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neoplasms, Second Primary; Pelvis; Pregnancy; Pregnancy Complications, Neoplastic; Transplantation, Autologous | 2002 |
Two cases of therapy-related acute promyelocytic leukemia (t-APL) after mantle cell lymphoma and gestational trophoblastic disease.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Arsenic Trioxide; Arsenicals; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leukemia, Promyelocytic, Acute; Lymphoma, Mantle-Cell; Male; Neoplasms, Second Primary; Oxides; Pregnancy; Tretinoin | 2002 |
Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides.
Topics: Acute Disease; Adolescent; Amino Acid Sequence; Child; Child, Preschool; Chromosome Breakage; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; DNA-Binding Proteins; Etoposide; Female; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia, Myeloid; Male; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Nuclear Proteins; Oncogene Proteins, Fusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Transcription Factors; Tumor Cells, Cultured | 2003 |
Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Bone Marrow; Case-Control Studies; Chemotherapy, Adjuvant; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; France; Humans; Leukemia; Male; Multivariate Analysis; Neoplasms; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Risk Assessment; Risk Factors | 2003 |
[Therapy-related acute myelogenous leukemia (AML-M6) with add(11) (q23) and del(20) (q11.2) developing via myelodysplastic syndrome after chemotherapy for malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 5; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leukemia, Erythroblastic, Acute; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Mitoguazone; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednisolone; Vinblastine; Vincristine | 2003 |
Hodgkin's disease--clinical trials and travails.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Mortality; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy; Vincristine | 2003 |
Development of secondary anaplastic oligoastrocytoma after matched unrelated bone marrow transplantation in a child with acute myeloid leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Astrocytoma; Bone Marrow Transplantation; Brain Neoplasms; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Etoposide; Female; Humans; Immunosuppressive Agents; Injections, Spinal; Leukemia, Monocytic, Acute; Male; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Parietal Lobe; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2003 |
Prostate carcinoma presenting as multiple pulmonary nodules in an asymptomatic patient with a history of testicular nonseminomatous germ cell tumor.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Flutamide; Humans; Leuprolide; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Orchiectomy; Postoperative Complications; Prostatic Neoplasms; Radiography; Testicular Neoplasms | 2003 |
[Metachronous testicular tumor of an extragonadal germ cell tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma in Situ; Cisplatin; Combined Modality Therapy; Diagnostic Imaging; Etoposide; Humans; Male; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Orchiectomy; Reoperation; Retroperitoneal Neoplasms; Testicular Neoplasms; Testis | 2003 |
[Simultaneous detection of both non-Hodgkin's lymphoma cells and breast cancer cells in pleural effusion--a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Combinations; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pleural Effusion; Prednisone; Tamoxifen; Tegafur; Uracil; Vincristine | 2003 |
Myelodysplastic syndrome (RARS) with +i(12p) abnormality in a patient 10 months after diagnosis and successful treatment of a mediastinal germ cell tumor (MGCT).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 12; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Myelodysplastic Syndromes; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Paclitaxel | 2004 |
MLL/AF-1p fusion in therapy-related early pre-B acute lymphoblastic leukemia with t(1;11)(p32;q23) translocation developing in the relapse phase of acute promyelocytic leukemia.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 11; Cytarabine; Daunorubicin; Enzyme Inhibitors; Etoposide; Fatal Outcome; Humans; Idarubicin; In Situ Hybridization, Fluorescence; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mitoxantrone; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms, Second Primary; Oncogene Proteins, Fusion; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Topoisomerase II Inhibitors; Translocation, Genetic; Tretinoin | 2003 |
[Tumor staging with PET/CT. Detection of a second tumor].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biopsy; Bronchoscopy; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Hypopharyngeal Neoplasms; Hypopharynx; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Radiography, Thoracic; Radiotherapy, Adjuvant; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carboplatin; Carcinoma, Embryonal; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Etoposide; Germinoma; Humans; Lymph Node Excision; Male; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasm Staging; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Orchiectomy; Prognosis; Risk Factors; Seminoma; Teratoma; Testicular Neoplasms; Treatment Outcome | 2004 |
Bifocal esophageal and rectal cancer palliatively treated with argon plasma coagulation.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Argon; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease Progression; Doxorubicin; Esophageal Neoplasms; Etoposide; Fatal Outcome; Humans; Light Coagulation; Male; Microsurgery; Neoplasms, Second Primary; Palliative Care; Rectal Neoplasms | 2004 |
ChlVPP/ABVVP, a first line 'hybrid' combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysis.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Disease-Free Survival; Doxorubicin; Etoposide; Female; Gastrointestinal Diseases; Hematologic Diseases; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasms, Second Primary; Procarbazine; Retrospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 2004 |
Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neuroectodermal Tumors, Primitive, Peripheral; Prognosis; Radiotherapy Dosage; Retrospective Studies; Sarcoma, Ewing; Treatment Failure; Vincristine | 2004 |
Therapy-related acute myeloid leukemia-like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion.
Topics: Acute Disease; Antigens, CD34; Cell Proliferation; Cells, Cultured; Clone Cells; DNA-Binding Proteins; Etoposide; Fetal Blood; Gene Rearrangement; Hematopoietic Stem Cells; Histone-Lysine N-Methyltransferase; Humans; Leukemia, Myeloid; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Proto-Oncogenes; Transcription Factors; Translocation, Genetic | 2005 |
Testicular seminoma after the complete remission of extragonadal yolk sac tumor : a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Endodermal Sinus Tumor; Etoposide; Humans; Male; Neoplasms, Second Primary; Orchiectomy; Remission Induction; Seminoma; Testicular Neoplasms; Ultrasonography | 2004 |
[CD56-positive peripheral T-cell lymphoma primarily presenting with tonsillar swelling].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; CD56 Antigen; Cyclophosphamide; Etoposide; Fatal Outcome; Female; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Humans; Ileal Neoplasms; Lymphoma, T-Cell; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Nitrosourea Compounds; Peripheral Blood Stem Cell Transplantation; Remission Induction; Tonsillar Neoplasms; Transplantation, Autologous | 2004 |
Coexistence of treatment-related MLL cleavage and rearrangement in a child with haemophagocytic lymphohistiocytosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Dexamethasone; DNA-Binding Proteins; Epstein-Barr Virus Infections; Etoposide; Gene Rearrangement; Histiocytosis, Non-Langerhans-Cell; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia, Myelomonocytic, Acute; Male; Methotrexate; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Nucleic Acid Synthesis Inhibitors; Polymerase Chain Reaction; Proto-Oncogenes; Time Factors; Topoisomerase II Inhibitors; Transcription Factors | 2004 |
Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Etoposide; Follow-Up Studies; Germany; Germinoma; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Mediastinal Neoplasms; Multicenter Studies as Topic; Myelodysplastic Syndromes; Neoplasms, Second Primary; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Testicular Neoplasms; Translocation, Genetic; Transplantation, Autologous | 2005 |
High cumulative rate of secondary leukemia after continuous etoposide treatment for solid tumors in children and young adults.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Case-Control Studies; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; France; Humans; Incidence; Infant; Leukemia; Male; Neoplasms; Neoplasms, Second Primary; Palliative Care; Survival Rate | 2005 |
DNA topoisomerase II in therapy-related acute promyelocytic leukemia.
Topics: Antineoplastic Agents; DNA Damage; DNA Repair; DNA Topoisomerases, Type II; DNA, Neoplasm; Doxorubicin; Etoposide; Humans; In Vitro Techniques; Leukemia, Promyelocytic, Acute; Mitoxantrone; Neoplasms, Second Primary; Polymerase Chain Reaction; Sequence Analysis, DNA; Topoisomerase II Inhibitors; Translocation, Genetic | 2005 |
Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dacarbazine; Etoposide; Female; Glioma; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Retrospective Studies; Survival Analysis; Temozolomide; Treatment Outcome | 2006 |
Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Magnetic Resonance Imaging; Male; Neoplasms, Second Primary; Prognosis; Radiotherapy Dosage; Retrospective Studies; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2006 |
T-cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia.
Topics: Acute Disease; Adolescent; Antigens, CD7; Antigens, Differentiation, T-Lymphocyte; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Cell Differentiation; Cell Lineage; Core Binding Factor Alpha 2 Subunit; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Diagnosis, Differential; Doxorubicin; Etoposide; Fatal Outcome; Female; Gene Dosage; Histone-Lysine N-Methyltransferase; Humans; Immunophenotyping; Karyotyping; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Mercaptopurine; Methotrexate; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Neoplastic Stem Cells; Proto-Oncogenes; Recurrence; T-Lymphocyte Subsets; Vincristine | 2007 |
[A case of therapy-related leukemia/myelodysplastic syndrome following treatment of refractory testicular germ cell tumor].
Topics: Adult; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Testicular Neoplasms | 2005 |
The outcome of children with acute myeloid leukemia (AML) post-allogeneic stem cell transplantation (SCT) is not improved by the addition of etoposide to the conditioning regimen.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Recurrence; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2006 |
Contralateral testicular cancer in spite of TIN-negative double biopsies and interval cisplatin chemotherapy.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cisplatin; Etoposide; False Negative Reactions; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Predictive Value of Tests; Sensitivity and Specificity; Testicular Neoplasms; Testis; Time Factors | 2006 |
Metachronous intracranial germinoma in a patient with a previous primary mediastinal seminoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Germinoma; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neurosurgical Procedures; Radiotherapy; Seminoma; Vinblastine | 2006 |
Successful treatment of refractory peripheral T-cell lymphoma with a combination of fludarabine and cyclophosphamide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Methylprednisolone; Neoplasms, Second Primary; Prednisone; Recurrence; Remission Induction; Time Factors; Vidarabine; Vincristine | 2006 |
VAD combination chemotherapy followed by bortezomib may be an effective treatment in secondary plasma cell leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Doxorubicin; Etoposide; Humans; Leukemia, Plasma Cell; Male; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Protease Inhibitors; Pyrazines; Remission Induction | 2006 |
Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lung Diseases; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Proportional Hazards Models; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Tumor Burden | 2006 |
Secondary glioblastoma multiforme after treatment for primary choroid plexus carcinoma in childhood.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Choroid Plexus Neoplasms; Cisplatin; Combined Modality Therapy; Diagnosis, Differential; Etoposide; Fatal Outcome; Glioblastoma; Humans; Male; Neoplasms, Second Primary; Vincristine | 2007 |
Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies.
Topics: Animals; Antineoplastic Agents; Disease Models, Animal; DNA Damage; DNA Topoisomerases, Type II; Drug Design; Etoposide; Isoenzymes; Melanoma, Experimental; Mice; Mice, Knockout; Neoplasms, Second Primary; Protease Inhibitors; Topoisomerase II Inhibitors | 2007 |
Childhood papillary thyroid cancer as second malignancy after successful treatment of rhabdomyosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Combined Modality Therapy; Dactinomycin; DNA, Neoplasm; Epirubicin; Etoposide; Humans; Ifosfamide; Infant; Iodine Radioisotopes; Male; Neoplasms, Second Primary; Rhabdomyosarcoma, Embryonal; Spinal Neoplasms; Thoracic Vertebrae; Thyroid Neoplasms; Thyroidectomy; Vincristine | 2008 |
Calla positive acute lymphoblastic leukemia after etoposide-based therapy for Ewing's sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Etoposide; Humans; Male; Neoplasms, Second Primary; Neprilysin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma, Ewing; Tibia | 1995 |
Osteosarcoma following radiation treatment for meningioma: report of a case and effective treatment with chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Dactinomycin; Etoposide; Female; Gonadotropin-Releasing Hormone; Humans; Ifosfamide; Lung Neoplasms; Meningeal Neoplasms; Meningioma; Methotrexate; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Osteosarcoma; Tamoxifen; Tomography, X-Ray Computed; Vincristine | 1994 |
Secondary tumours following etoposide containing therapy for germ cell cancer.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Cytarabine; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Germinoma; Humans; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Neoplasms, Second Primary; Testicular Neoplasms; Vincristine | 1995 |
Pseudoleukemia after granulocyte colony-stimulating factor therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myelomonocytic, Acute; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasms, Second Primary; Neutropenia; Prednisone; Vincristine | 1995 |
[Secondary myeloid/natural killer cell acute leukemia appeared in multiple myeloma treated with melphalan].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Etoposide; Fatal Outcome; Female; Humans; Killer Cells, Natural; Leukemia, Myeloid, Acute; Melphalan; Multiple Myeloma; Neoplasms, Second Primary; Prednisolone | 1995 |
Therapy-related acute myelomonocytic leukemia following successful treatment for acute promyelocytic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytarabine; Etoposide; Female; Humans; Idarubicin; Karyotyping; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Mercaptopurine; Methotrexate; Mitoxantrone; Neoplasms, Second Primary; Remission Induction; Thioguanine; Translocation, Genetic | 1995 |
Risk of secondary leukemia following high cumulative doses of etoposide during chemotherapy for testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Leukemia; Male; Neoplasms, Second Primary; Testicular Neoplasms | 1995 |
Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Leukemia; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Retrospective Studies; Salvage Therapy; Testicular Neoplasms; Translocation, Genetic | 1993 |
Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Leukemia, Myeloid, Acute; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Remission Induction; Salvage Therapy; Testicular Neoplasms; Vinblastine | 1993 |
ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children.
Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Chromosome Aberrations; Chromosome Deletion; Chromosomes, Human, Pair 11; Combined Modality Therapy; Dactinomycin; DNA-Binding Proteins; Etoposide; Female; Genes; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Myelodysplastic Syndromes; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Radiotherapy; Teniposide; Topoisomerase II Inhibitors; Transcription Factors; Translocation, Genetic; Whole-Body Irradiation | 1995 |
The price of success.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Etoposide; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Neoplasms, Second Primary | 1995 |
Translocation t(11;11)(q13;q23) and HRX gene rearrangement associated with therapy-related leukemia in a child previously treated with VP16.
Topics: Adolescent; Blotting, Southern; Chromosomes, Human, Pair 11; DNA-Binding Proteins; Etoposide; Female; Gene Rearrangement; Histone-Lysine N-Methyltransferase; Humans; In Situ Hybridization, Fluorescence; Karyotyping; Leukemia, Monocytic, Acute; Leukemia, Myelomonocytic, Acute; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Proto-Oncogenes; Transcription Factors; Translocation, Genetic | 1994 |
Acute myelomonocytic leukemia after treatment with chronic oral etoposide: are MLL and LTG9 genes targets for etoposide?
Topics: Administration, Oral; Aged; Base Sequence; Carcinoma, Small Cell; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Drug Administration Schedule; Etoposide; Genes; Humans; Leukemia, Myelomonocytic, Acute; Lung Neoplasms; Male; Molecular Sequence Data; Neoplasms, Second Primary; Polymerase Chain Reaction; Translocation, Genetic | 1994 |
[Secondary leukemia after etoposide treatment involved MLL gene rearrangement].
Topics: Chromosomes, Human, Pair 11; Etoposide; Gene Rearrangement; Humans; Leukemia, Myeloid, Acute; Lymphoma, T-Cell; Male; Middle Aged; Neoplasms, Second Primary; Translocation, Genetic | 1994 |
Epipodophyllotoxins and secondary leukaemia.
Topics: Etoposide; Humans; Leukemia, Myeloid, Acute; Neoplasms, Second Primary; Podophyllotoxin | 1993 |
A case of recurrent intramural uterine stromal tumor with epithelial differentiation effectively treated with oral low-dose administration of etoposide.
Topics: Administration, Oral; Aged; Etoposide; Female; Humans; Neoplasms, Second Primary; Sex Cord-Gonadal Stromal Tumors; Uterine Neoplasms | 1994 |
Therapy-related acute myelogenous leukemia associated with 11q23 chromosomal abnormalities and topoisomerase II inhibitors: report of four additional cases and brief commentary.
Topics: Adult; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged; Neoplasms, Second Primary; Topoisomerase II Inhibitors; Translocation, Genetic | 1993 |
[Neoadjuvant chemotherapy effective for small cell lung cancer in a nephrectomized patient].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Renal Cell; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Male; Neoplasms, Second Primary; Nephrectomy | 1993 |
Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Chromosome Aberrations; Cisplatin; Cohort Studies; Denmark; DNA Topoisomerases, Type II; DNA, Neoplasm; Etoposide; Female; Germinoma; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms; Neoplasms, Second Primary; Regression Analysis; Risk | 1993 |
Human trithorax gene rearrangements in therapy-related acute leukaemia after etoposide treatment.
Topics: Adult; Aged; Animals; Blotting, Southern; Chromosomes, Human, Pair 11; Drosophila; Etoposide; Female; Gene Rearrangement; Genes, Regulator; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasms, Second Primary; Sequence Homology, Nucleic Acid; Translocation, Genetic | 1994 |
Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia.
Topics: Child, Preschool; Chromosomes, Human, Pair 11; DNA-Cytosine Methylases; DNA, Neoplasm; Etoposide; Humans; Leukemia, Monocytic, Acute; Male; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Translocation, Genetic | 1993 |
Etoposide and secondary haematological malignancies: coincidence or causality?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Chromosome Aberrations; Chromosome Disorders; Etoposide; Female; Hematologic Diseases; Hodgkin Disease; Humans; Karyotyping; Lung Neoplasms; Male; Middle Aged; Neoplasms, Second Primary | 1993 |
Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide.
Topics: Acute Disease; Adolescent; Bone Marrow; Burkitt Lymphoma; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Risk; Treatment Outcome | 1993 |
High frequency of etoposide (VP-16)-related secondary leukemia in children with non-Hodgkin's lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparagine; Child; Child, Preschool; Chromosome Aberrations; Chromosomes, Human, Pair 11; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Life Tables; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Neoplasms, Second Primary; Risk; Vincristine | 1993 |
Report of the Cancer Therapy Evaluation Program monitoring plan for secondary acute myeloid leukemia following treatment with epipodophyllotoxins.
Topics: Acute Disease; Adult; Child; Clinical Trials as Topic; Etoposide; Humans; Incidence; Leukemia, Myeloid; Myelodysplastic Syndromes; Neoplasms, Second Primary; Podophyllotoxin | 1993 |
Re: "Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X)" by Viana et al.
Topics: Child; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Leukemia, Myeloid, Acute; Neoplasms, Second Primary | 1993 |
Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Base Sequence; Binding Sites; Centromere; Child; Child, Preschool; Chromatin; Chromosomes, Human, Pair 11; Consensus Sequence; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Etoposide; Female; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia; Male; Middle Aged; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Proto-Oncogenes; Telomere; Teniposide; Topoisomerase II Inhibitors; Transcription Factors; Translocation, Genetic; Tumor Cells, Cultured | 1996 |
True histiocytic lymphoma following therapy for lymphoblastic neoplasms.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Mercaptopurine; Methotrexate; Methylprednisolone; Neoplasms, Second Primary; Neoplastic Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Remission Induction; Scapula; Spinal Neoplasms; Vincristine | 1996 |
[A case of early gastric cancer transformed from adenoma by chemotherapy and radiotherapy].
Topics: Adenoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Liver Neoplasms; Lymphoma; Male; Neoplasms, Second Primary; Prednisolone; Stomach Neoplasms; Tegafur; Uracil; Vincristine | 1996 |
[Therapy-related AML(M2) with t(8;21) that developed three years after chemotherapy for hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Doxorubicin; Epirubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Liver Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Translocation, Genetic | 1996 |
Secondary acute myelogenous leukemia following treatment with oral etoposide.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Estramustine; Etoposide; Humans; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Prostatic Neoplasms | 1996 |
Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Incidence; Methotrexate; Middle Aged; Neoplasms, Second Primary; Pregnancy; Time Factors; Trophoblastic Neoplasms; Uterine Neoplasms | 1996 |
[Successful treatment of combined interferon-alpha and hydroxycarbamide for chronic myelogenous leukemia following therapy for malignant lymphoma].
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etoposide; Female; Humans; Hydroxyurea; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Follicular; Middle Aged; Neoplasms, Second Primary | 1996 |
Relationship between cytotoxicity and site-specific DNA recombination after in vitro exposure of leukemia cells to etoposide.
Topics: Acute Disease; Antineoplastic Agents, Phytogenic; Base Sequence; DNA Primers; DNA, Neoplasm; Etoposide; Exons; Gene Rearrangement; Humans; Leukemia; Leukemia, Myeloid; Molecular Sequence Data; Neoplasms, Second Primary; Sequence Deletion; Time Factors; Tumor Cells, Cultured | 1996 |
Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma.
Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Burkitt Lymphoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Duodenal Neoplasms; Etoposide; Humans; Immunocompromised Host; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Neoplasms, Second Primary; Pancytopenia; Remission Induction; Salvage Therapy; Thigh; Transplantation Conditioning; Vincristine | 1996 |
Residual mass following chemotherapy of seminoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Fibrosis; Humans; Life Tables; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Retrospective Studies; Salvage Therapy; Seminoma; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Vinblastine | 1997 |
Cisplatin-based chemotherapy changes the incidence of bilateral testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Functional Laterality; Humans; Male; Neoplasms, Second Primary; Testicular Neoplasms | 1997 |
Secondary acute myelogenous leukemia following safe exposure to etoposide.
Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Phytogenic; Child; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary | 1997 |
Molecular analysis of the t(15;17) translocation in de novo and secondary acute promyelocytic leukemia.
Topics: Antineoplastic Agents, Phytogenic; Base Sequence; Blotting, Southern; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Consensus Sequence; Etoposide; Humans; Introns; Leukemia, Promyelocytic, Acute; Neoplasm Proteins; Neoplasms, Second Primary; Nuclear Proteins; Promyelocytic Leukemia Protein; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Transcription Factors; Translocation, Genetic; Tumor Suppressor Proteins | 1997 |
[Small cell lung cancer with acute monocytic leukemia after combined chemotherapy including etoposide].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Humans; Leukemia, Monocytic, Acute; Lung Neoplasms; Middle Aged; Neoplasms, Second Primary | 1997 |
Chemotherapy-related - late occurring - Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors?
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Doxorubicin; Enzyme Inhibitors; Etoposide; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Topoisomerase II Inhibitors | 1997 |
[Acute myelogenous leukemia (M4) occurring during chronic lymphocytic leukemia].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Estradiol; Etoposide; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelomonocytic, Acute; Male; Neoplasms, Second Primary | 1997 |
Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia.
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Erythrocytes; Etoposide; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Metabolic Clearance Rate; Methyltransferases; Models, Biological; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Regression Analysis; Serum Albumin; Time Factors | 1998 |
Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease: a prospective study.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Mitoguazone; Neoplasms, Second Primary; Prospective Studies; Salvage Therapy; Survival Analysis | 1998 |
Therapy-related leukemia and myelodysplasia following oral administration of etoposide for recurrent breast cancer.
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Breast Neoplasms; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Recurrence; Risk Factors | 1998 |
Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myelomonocytic, Acute; Male; Mediastinal Neoplasms; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Retroperitoneal Neoplasms; Retrospective Studies; Testicular Neoplasms | 1998 |
Secondary acute myeloid leukemia following treatment with VP16-containing regimens for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Enzyme Inhibitors; Etoposide; Fatal Outcome; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leukemia, Monocytic, Acute; Leukemia, Myelomonocytic, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Methotrexate; Mitoxantrone; Neoplasm Proteins; Neoplasms, Second Primary; Prednisone; Topoisomerase II Inhibitors; Vincristine | 1998 |
New retinoblastoma tumors in children undergoing systemic chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Cryotherapy; Etoposide; Female; Fundus Oculi; Humans; Hyperthermia, Induced; Infant; Male; Neoplasms, Second Primary; Retinal Neoplasms; Retinoblastoma; Vincristine | 1998 |
Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Monitoring; Etoposide; Female; Follow-Up Studies; Humans; Infant; Leukemia; Male; Myelodysplastic Syndromes; Neoplasms, Second Primary; Risk Factors | 1999 |
Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Bone Marrow Purging; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Progression; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Length of Stay; Leukemia, Myeloid; Male; Mechlorethamine; Middle Aged; Mitoxantrone; Neoplasms, Second Primary; Neoplastic Stem Cells; Pilot Projects; Platelet Transfusion; Recurrence; Remission Induction; Risk; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vidarabine | 1999 |
The inv(11)(p15q22) chromosome translocation of therapy-related myelodysplasia with NUP98-DDX10 and DDX10-NUP98 fusion transcripts.
Topics: Cell Transformation, Neoplastic; Chromosomes, Human, Pair 11; Etoposide; Humans; Leukemia, Myelomonocytic, Acute; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Transcription, Genetic; Translocation, Genetic | 1999 |
Acute myelogenous leukemia after treatment for malignant germ cell tumors in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Infant; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Risk Factors; Vinblastine | 1999 |
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Child, Preschool; Chlorambucil; Cohort Studies; Combined Modality Therapy; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Incidence; Infant; Leukemia, Myeloid; Life Tables; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Podophyllotoxin; Prednisolone; Prednisone; Procarbazine; Retrospective Studies; Risk; Salvage Therapy; Vinblastine; Vincristine | 1999 |
Outcome and reproductive function after chemotherapy for ovarian dysgerminoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Disease-Free Survival; Dysgerminoma; Etoposide; Female; Follow-Up Studies; Humans; Menstrual Cycle; Neoplasms, Second Primary; Ovarian Neoplasms; Ovariectomy; Pregnancy Rate; Retrospective Studies | 1999 |
[Mechanism of occurrence of secondary tumors by antitumor drugs].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; DNA Repair; DNA Topoisomerases, Type II; DNA-Binding Proteins; Doxorubicin; Etoposide; Histone-Lysine N-Methyltransferase; Humans; Leukemia; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Proto-Oncogenes; Topoisomerase II Inhibitors; Transcription Factors; Translocation, Genetic | 1999 |
Novel SH3 protein encoded by the AF3p21 gene is fused to the mixed lineage leukemia protein in a therapy-related leukemia with t(3;11) (p21;q23).
Topics: Adaptor Proteins, Signal Transducing; Adolescent; Amino Acid Sequence; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; DNA, Complementary; Etoposide; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Monocytic, Acute; Molecular Sequence Data; Muscle Proteins; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Nitrosourea Compounds; Nuclear Proteins; Oncogene Proteins, Fusion; Sequence Alignment; Sequence Homology, Nucleic Acid; src Homology Domains | 2000 |
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; California; Case-Control Studies; Cohort Studies; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Leukemia, Radiation-Induced; Lymphoma; Male; Middle Aged; Multivariate Analysis; Myelodysplastic Syndromes; Neoplasms, Second Primary; Odds Ratio; Radiotherapy; Retrospective Studies; Risk Factors; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation | 2000 |
Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Cataract; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infections; Life Tables; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prognosis; Remission Induction; Retrospective Studies; Survival Analysis; Sweden; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation | 2000 |
A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Cell Cycle; Cisplatin; Cyclophosphamide; Dexamethasone; Etoposide; Flow Cytometry; Humans; Immunoglobulin kappa-Chains; Immunoglobulin lambda-Chains; Leukemia, Plasma Cell; Male; Multiple Myeloma; Neoplasms, Second Primary; Prognosis; Thalidomide | 2000 |
Acute myeloid leukemia and lung cancer occurring in a chronic lymphocytic leukemia patient treated with fludarabine and autologous peripheral blood stem-cell transplantation.
Topics: Acute Disease; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Fatal Outcome; Genetic Predisposition to Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Lung Neoplasms; Male; Middle Aged; Neoplasm, Residual; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Recombinant Proteins; Risk; Smoking; Transplantation Conditioning; Transplantation, Autologous; Vidarabine | 2000 |
Topoisomerase II inhibitor induced leukemia in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Homosexuality, Male; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Metastasis; Neoplasms, Second Primary; Topoisomerase II Inhibitors | 2001 |
Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Incidence; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Transplantation, Autologous | 2001 |
Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Catechols; Child; Chromosome Breakage; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Etoposide; Female; Histone-Lysine N-Methyltransferase; Humans; Ifosfamide; Isoenzymes; Models, Genetic; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms, Second Primary; Nuclear Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Radiotherapy, Adjuvant; Recombination, Genetic; Rhabdomyosarcoma, Alveolar; Soft Tissue Neoplasms; Transcription Factors; Transcriptional Elongation Factors; Translocation, Genetic; Vincristine | 2001 |
Two secondary leukemias among 15 children given oral etoposide.
Topics: Child; Etoposide; Humans; Leukemia, Monocytic, Acute; Leukemia, Promyelocytic, Acute; Neoplasms, Second Primary; Neuroblastoma | 2001 |
Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Topics: Antineoplastic Agents, Phytogenic; Child, Preschool; Cyclosporine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Neoplasms, Second Primary | 2001 |
Acute myeloblastic leukemia as a second malignancy in a patient with hereditary retinoblastoma.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Neoplasms, Second Primary; Retinal Neoplasms; Retinoblastoma | 2001 |
Acute myeloid leukemia with t(11;19)(q23;p13) developing in an adult T-cell leukemia patient treated with combined chemotherapy including etoposide.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 19; Etoposide; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Middle Aged; Neoplasms, Second Primary; Translocation, Genetic | 2001 |
Lactic Acidosis in Non-Hodgkin's Lymphoma and response to Chemotherapy.
Topics: Acidosis, Lactic; Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colonic Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Humans; Lactates; Liver; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasms, Second Primary; Prednisone; Sodium Bicarbonate; Vincristine | 2002 |
Secondary acute promyelocytic leukemia in a patient with non-Hodgkin's lymphoma treated with VP-16 and MST-16.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasm Proteins; Neoplasms, Second Primary; Oncogene Proteins, Fusion; Piperazines; Prednisolone; Remission Induction; Tretinoin; Vincristine | 2002 |
Renal cell carcinoma as a secondary malignancy after treatment of acute promyelocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cerebral Infarction; Child; Chromosomes, Human, Pair 17; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Humans; Hypertension; Kidney Failure, Chronic; Leukemia, Promyelocytic, Acute; Male; Neoplasms, Second Primary; Obesity; Remission Induction; Thioguanine | 2001 |
Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue.
Topics: Acyclovir; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carboplatin; Central Nervous System Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Epstein-Barr Virus Infections; Etoposide; Eye Enucleation; Eye Neoplasms; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Lymphoma, Large B-Cell, Diffuse; Male; Meningeal Neoplasms; Methylprednisolone; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Optic Nerve Neoplasms; Radiotherapy, Adjuvant; Retinoblastoma; Rituximab; Thiotepa; Vincristine | 2002 |
Translocation (11;11)(p13- p15;q23) in a child with therapy-related acute myeloid leukemia following chemotherapy with DNA-topoisomerase II inhibitors for Langerhans cell histiocytosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Chromosomes, Human, Pair 11; Cytarabine; Drug Therapy, Combination; Enzyme Inhibitors; Etoposide; Fatal Outcome; Histiocytosis, Langerhans-Cell; Humans; Idarubicin; Karyotyping; Leukemia, Myelomonocytic, Acute; Male; Neoplasms, Second Primary; Nuclear Pore Complex Proteins; Prednisolone; Topoisomerase II Inhibitors; Translocation, Genetic; Vinblastine | 2002 |
Secondary lymphoblastic leukemia following treatment of a malignant germ cell tumour.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Testicular Neoplasms | 1992 |
Management of stage II Hodgkin's disease: 15 years experience at St. Bartholomew's Hospital.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Diaphragm; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lymphatic Diseases; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Vinblastine; Vincristine | 1992 |
ABEP as primary chemotherapy for Hodgkin's disease.
Topics: Aclarubicin; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Male; Mechlorethamine; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednisolone; Prednisone; Procarbazine; Vincristine | 1992 |
New perspectives on the toxicity of etoposide.
Topics: Bone Marrow Diseases; Etoposide; Humans; Leukemia; Neoplasms, Second Primary; Podophyllotoxin | 1992 |
Secondary pre-leukaemia and etoposide.
Topics: Etoposide; Humans; Leukemia, Myeloid, Acute; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Neural Tube Defects | 1991 |